ACM
AMGN icon

Accent Capital Management’s Amgen AMGN Stock Holding History

Accent Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21
Closed -$5.86K – 377
2025
Q2 		$5.86K Hold
21
– – ﹤0.01% 317
2025
Q1 		$6.54K Hold
21
– – ﹤0.01% 228
2024
Q4 		$5.47K Hold
21
– – ﹤0.01% 168
2024
Q3 		$6.77K Hold
21
– – ﹤0.01% 185
2024
Q2 		$6.56K Hold
21
– – ﹤0.01% 158
2024
Q1 		$5.97K Hold
21
– – 0.01% 143
2023
Q4 		$6.05K Buy
+21
New +$5.72K ﹤0.01% 184

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Accent Capital Management's AMGN Position: Q3 2025 in Review

Accent Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 21 shares — an estimated $5.86K sold.

Accent Capital Management first reported a position in AMGN in Q4 2023 and held it in 7 quarters. The position peaked at $6.77K in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Accent Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Accent Capital Management sold 21 Amgen shares in Q3 2025, an estimated $5.86K.
  • Accent Capital Management first reported a position in Amgen in Q4 2023 and held it in 7 quarters.
  • Accent Capital Management's Amgen position peaked at $6.77K in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Accent Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.